No info available.

• American Association of Colleges of Pharmacy New Investigator Award (01/01/2021-01/31/2021)

• Ph D in Health Outcomes , The University of Texas at Austin (2019)

• The association between hydroxyurea adherence and opioid utilization among Texas Medicaid enrollees with sickle cell disease Journal of Managed Care & specialty Pharmacy (JMCP) 26 11 (2020), Hyeun Ah Kang, Jamie C. Barner.
• Association between Vaso-occlusive Crises and Opioid Prescriptions among Patients with Sickle Cell Disease: A Retrospective Claims-based Study Journal of Health Economics and Outcomes Research 7 1 (2020), Hyeun Ah Kang, Jamie C. Barner, Kristin M. Richards, Menaka Bohr, Jincy Paulose, Abdullah Kutlar.
• 6- Composite Article 1: CUA - Oncology Wolters Kluwer Health (in press), Hyeun Ah Kang.
• Bioreducible Poly(ethylene glycol)-Triphenylphosphonium Conjugate as a Bioactivable Mitochondria-Targeting Nanocarrier. Biomacromolecules 18 4 (2017), Z Khatun, Y S. Choi, Youngcho Kim, K Yoon, Md Nurunnabi, L Li , E Lee, Hyeun Ah Kang, K M. Huh.

• Adherence to Hydroxyurea and Its Association with Clinical and Economic Outcomes among Texas Medicaid Enrollees with Sickle Cell Disease (2020), Volume UTEP School of Pharmacy Room 214, Hyeun Ah Kang.

• Unintended consequences of the 2016 CDC Guideline for sickle cell disease patients
• Rural Health Interdisciplinary Research Core
• Research Collaborations with Restrictive Micro-Data